Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.6K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Structure and Function of Platelets01:18

Structure and Function of Platelets

6.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.8K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

2.5K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.5K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

9.5K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapy-related myeloid neoplasms following peptide receptor radionuclide therapy for neuroendocrine neoplasms: case series reporting characteristics and outcomes from single-centre experience.

Endocrine oncology (Bristol, England)·2026
Same author

Measurable Residual Disease detection in acute lymphoblastic leukaemia: comparison between targeted NGS and ASO-RQPCR.

Pathology·2026
Same author

Catheter Ablation vs Sotalol or Amiodarone for Ventricular Tachycardia: A Substudy of the VANISH2 Trial.

Journal of the American College of Cardiology·2025
Same author

Neurological manifestations of chronic graft versus host disease.

Internal medicine journal·2025
Same author

ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APL.

Blood advances·2025
Same author

Distribution of myocardial fibrosis in patients with nonischemic cardiomyopathy and ventricular tachycardia based on genetic variant.

Heart rhythm·2024

Related Experiment Video

Updated: Apr 25, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.4K

Inherited macrothrombocytopenias.

David John Rabbolini1, Marie Christine Morel-Kopp1, William Stevenson1

  • 1Department of Haematology and Transfusion Medicine, Royal North Shore Hospital, Sydney, New South Wales, Australia.

Seminars in Thrombosis and Hemostasis
|September 1, 2014
PubMed
Summary

Inherited macrothrombocytopenias cause bleeding but are often misdiagnosed. Genetic testing is improving diagnosis and understanding of these rare platelet disorders.

More Related Videos

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants
05:58

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants

Published on: May 20, 2021

2.1K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K

Related Experiment Videos

Last Updated: Apr 25, 2026

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
09:46

Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells

Published on: December 27, 2017

19.4K
Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants
05:58

Proplatelet Formation Dynamics of Mouse Fresh Bone Marrow Explants

Published on: May 20, 2021

2.1K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K

Area of Science:

  • Hematology
  • Genetics
  • Clinical Medicine

Background:

  • Inherited macrothrombocytopenias are rare bleeding disorders.
  • These conditions are often misdiagnosed as immune thrombocytopenia purpura.
  • Traditional diagnosis relies on phenotypic assessment.

Purpose of the Study:

  • To review the expanding classification of inherited macrothrombocytopenias.
  • To discuss the pathophysiology of these disorders.
  • To highlight the role of genetic testing in diagnosis.

Main Methods:

  • Literature review of inherited macrothrombocytopenias.
  • Analysis of diagnostic strategies, including phenotypic and genetic testing.
  • Discussion of recent advances in next-generation sequencing.

Main Results:

  • Inherited macrothrombocytopenias encompass a heterogeneous group of disorders.
  • Genetic testing has significantly advanced the understanding of pathogenesis and classification.
  • Next-generation sequencing aids in accurate diagnosis.

Conclusions:

  • A growing number of inherited macrothrombocytopenias are being identified.
  • Integrated phenotypic and genetic testing is crucial for accurate diagnosis.
  • Improved diagnostic approaches enhance patient care and understanding of these conditions.